Serotonin and mental disorders: A concise review on molecular neuroimaging evidence

Shih Hsien Lin, Lan Ting Lee, Yen Kuang Yang

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Serotonin is one of the most important neurotransmitters influencing mental health and, thus, is a potential target for pharmacological treatments. Functional neuroimaging techniques, such as positron-emission tomography (PET) and single photon emission computed tomography (SPECT), could provide persuasive evidence for the association between mental disorders and serotonin. In this concise review, we focus on evidence of the links between serotonin and major depressive disorders, as well as other mood disorders, anxiety disorders, schizophrenia, addiction, attention deficit hyperactivity disorder (ADHD), and autism.

Original languageEnglish
Pages (from-to)196-202
Number of pages7
JournalClinical Psychopharmacology and Neuroscience
Volume12
Issue number3
DOIs
Publication statusPublished - 2014 Dec 1

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Serotonin and mental disorders: A concise review on molecular neuroimaging evidence'. Together they form a unique fingerprint.

  • Cite this